PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29914794-5	2018	Mechanistically, pinocembrin suppresses activation of the MAPK kinase p38 and NF-kappaB pathways in the context of ox-LDL.	pinocembrin	17-28	mitogen-activated protein kinase 14	Homo sapiens	70-73	
25949790-0	2014	Pinocembrin suppresses TGF-beta1-induced epithelial-mesenchymal transition and metastasis of human Y-79 retinoblastoma cells through inactivating alphavbeta3 integrin/FAK/p38alpha signaling pathway.	pinocembrin	0-11	mitogen-activated protein kinase 14	Homo sapiens	171-179	
25949790-5	2014	Molecular data also showed pinocembrin inhibits the activation of focal adhesion kinase (FAK) and p38alpha signal involved in the downregulation of enzyme activities, protein and messenger RNA levels of matrix metalloproteinase-2/9 (MMP-2/-9) induced by TGF-beta1.	pinocembrin	27-38	mitogen-activated protein kinase 14	Homo sapiens	98-106	
25949790-8	2014	CONCLUSIONS: Presented results indicated that pinocembrin inhibits TGF-beta1-induced epithelial-mesenchymal transition (EMT) and metastasis of Y-79 cells by inactivating the alphavbeta3 integrin/FAK/p38alpha signaling pathway.	pinocembrin	46-57	mitogen-activated protein kinase 14	Homo sapiens	199-207